Keywords: Roche, Zelboraf, EMA, Daiichi Sankyo, Metastatic melanoma

EMA recommends approval of Roche’s Zelboraf

Article | 19 December 2011

Print This

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended the granting of a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in